148 related articles for article (PubMed ID: 22004266)
1. Fatal pandemic influenza A/H1N1 infection complicated by probable invasive pulmonary aspergillosis.
Kim SH; Kim MN; Lee SO; Choi SH; Kim YS; Woo JH; Lim CM; Koh Y; Hong SB
Mycoses; 2012 Mar; 55(2):189-92. PubMed ID: 22004266
[No Abstract] [Full Text] [Related]
2. Influenza A (H1N1) in a pediatric patient with newly diagnosed acute promyelocytic leukemia and invasive pulmonary aspergillosis.
Vallero S; Carraro F; Fagioli F; Postini AM; Rivetti E; Bezzio S; Giacchino M
J Pediatr Hematol Oncol; 2011 Oct; 33(7):562-4. PubMed ID: 21941151
[TBL] [Abstract][Full Text] [Related]
3. Invasive pulmonary aspergillosis in severe complicated influenza A.
Toh HS; Jiang MY; Tay HT
J Formos Med Assoc; 2013 Dec; 112(12):810-1. PubMed ID: 24262920
[No Abstract] [Full Text] [Related]
4. Mixtures of oseltamivir-sensitive and -resistant pandemic influenza A/H1N1/2009 viruses in immunocompromised hospitalized children.
Suhaila M; Tang JW; Lee HK; Lin C; Tambyah PA; Yap HK; Quak SH; Koay ES
Pediatr Infect Dis J; 2011 Jul; 30(7):625-7. PubMed ID: 21206398
[TBL] [Abstract][Full Text] [Related]
5. Impact of early oseltamivir treatment on outcome in critically ill patients with 2009 pandemic influenza A.
Rodríguez A; Díaz E; Martín-Loeches I; Sandiumenge A; Canadell L; Díaz JJ; Figueira JC; Marques A; Alvarez-Lerma F; Vallés J; Baladín B; García-López F; Suberviola B; Zaragoza R; Trefler S; Bonastre J; Blanquer J; Rello J;
J Antimicrob Chemother; 2011 May; 66(5):1140-9. PubMed ID: 21385717
[TBL] [Abstract][Full Text] [Related]
6. Pericardial effusion complicating novel influenza A (H1N1) infection in an infant.
Koranyi K; Yontz D; Rohrer Z; Leber A; Ramilo O
Pediatr Infect Dis J; 2010 Aug; 29(8):782-3. PubMed ID: 20661108
[TBL] [Abstract][Full Text] [Related]
7. Pandemic 2009 influenza A(H1N1) virus infection coinciding with invasive pulmonary aspergillosis in neutropenic patients.
Vehreschild JJ; Bröckelmann PJ; Bangard C; Verheyen J; Vehreschild MJ; Michels G; Wisplinghoff H; Cornely OA
Epidemiol Infect; 2012 Oct; 140(10):1848-52. PubMed ID: 22152763
[TBL] [Abstract][Full Text] [Related]
8. Failure of combination oral oseltamivir and inhaled zanamivir antiviral treatment in ventilator- and ECMO-treated critically ill patients with pandemic influenza A (H1N1)v.
Petersen E; Keld DB; Ellermann-Eriksen S; Gubbels S; Ilkjær S; Jensen-Fangel S; Lindskov C
Scand J Infect Dis; 2011 Jul; 43(6-7):495-503. PubMed ID: 21309638
[TBL] [Abstract][Full Text] [Related]
9. Oseltamivir-zanamivir bitherapy compared to oseltamivir monotherapy in the treatment of pandemic 2009 influenza A(H1N1) virus infections.
Escuret V; Cornu C; Boutitie F; Enouf V; Mosnier A; Bouscambert-Duchamp M; Gaillard S; Duval X; Blanchon T; Leport C; Gueyffier F; Van Der Werf S; Lina B
Antiviral Res; 2012 Nov; 96(2):130-7. PubMed ID: 22909899
[TBL] [Abstract][Full Text] [Related]
10. Possible neuropsychiatric reaction to high-dose oseltamivir during acute 2009 H1N1 influenza A infection.
Nakamura K; Schwartz BS; Lindegårdh N; Keh C; Guglielmo BJ
Clin Infect Dis; 2010 Apr; 50(7):e47-9. PubMed ID: 20192728
[TBL] [Abstract][Full Text] [Related]
11. Invasive aspergillosis after pandemic (H1N1) 2009.
Lat A; Bhadelia N; Miko B; Furuya EY; Thompson GR
Emerg Infect Dis; 2010 Jun; 16(6):971-3. PubMed ID: 20507748
[TBL] [Abstract][Full Text] [Related]
12. Influenza A/H1N1 2009 pneumonia in kidney transplant recipients: characteristics and outcomes following high-dose oseltamivir exposure.
Watcharananan SP; Suwatanapongched T; Wacharawanichkul P; Chantratitaya W; Mavichak V; Mossad SB
Transpl Infect Dis; 2010 Apr; 12(2):127-31. PubMed ID: 20102550
[TBL] [Abstract][Full Text] [Related]
13. Postinfluenza A(H3N2) refractory invasive pulmonary aspergillosis.
Ku YH; Chuang YC; Yu WL
J Formos Med Assoc; 2017 May; 116(5):404-405. PubMed ID: 27727000
[No Abstract] [Full Text] [Related]
14. Fatal cases of pandemic (H1N1) 2009 influenza despite their early antiviral treatment in Japan.
Nukiwa N; Kamigaki T; Oshitani H
Clin Infect Dis; 2010 Oct; 51(8):993-4. PubMed ID: 20858082
[No Abstract] [Full Text] [Related]
15. Early versus late oseltamivir treatment in severely ill patients with 2009 pandemic influenza A (H1N1): speed is life.
Kumar A
J Antimicrob Chemother; 2011 May; 66(5):959-63. PubMed ID: 21406435
[TBL] [Abstract][Full Text] [Related]
16. 2009 Influenza A H1N1 infections: delays in starting treatment with oseltamivir were associated with a more severe disease.
Launes C; García-García JJ; Jordán I; Martínez-Planas A; Selva L; Muñoz-Almagro C
Pediatr Infect Dis J; 2011 Jul; 30(7):622-5. PubMed ID: 21200359
[TBL] [Abstract][Full Text] [Related]
17. Novel H1N1 influenza in neonates: from mild to fatal disease.
Martic J; Savic N; Minic P; Pasic S; Nedeljkovic J; Jankovic B
J Perinatol; 2011 Jun; 31(6):446-8. PubMed ID: 21617702
[TBL] [Abstract][Full Text] [Related]
18. Fatal oseltamivir-resistant influenza virus infection.
van der Vries E; van den Berg B; Schutten M
N Engl J Med; 2008 Sep; 359(10):1074-6. PubMed ID: 18768958
[No Abstract] [Full Text] [Related]
19. Hemophagocytic lymphohistiocytosis associated with 2009 pandemic influenza A (H1N1) virus infection.
Ozdemir H; Çiftçi E; Ince EU; Ertem M; Ince E; Doğru U
J Pediatr Hematol Oncol; 2011 Mar; 33(2):135-7. PubMed ID: 21285906
[TBL] [Abstract][Full Text] [Related]
20. Pandemic (H1N1) 2009 virus infection: persistent viral shedding after Oseltamivir treatment.
Kanchana S; Kanchana S; Chuntrakul C; Malathum K; Prachayangprecha S; Poovorawan Y
J Infect; 2011 Oct; 63(4):295-9. PubMed ID: 21840339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
